International Biotechnology (LON:IBT – Get Free Report)’s share price passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 657.46 ($8.79) and traded as high as GBX 682 ($9.12). International Biotechnology shares last traded at GBX 676 ($9.04), with a volume of 31,526 shares trading hands.
International Biotechnology Stock Performance
The company has a debt-to-equity ratio of 9.66, a current ratio of 0.46 and a quick ratio of 0.32. The company has a fifty day moving average of GBX 681.65 and a two-hundred day moving average of GBX 657.54. The stock has a market capitalization of £246.15 million, a P/E ratio of 1,387.50 and a beta of 0.21.
Insider Buying and Selling at International Biotechnology
In related news, insider Gillian Elcock bought 1,407 shares of the firm’s stock in a transaction on Wednesday, July 24th. The stock was bought at an average cost of GBX 709 ($9.48) per share, for a total transaction of £9,975.63 ($13,343.54). 4.18% of the stock is currently owned by insiders.
International Biotechnology Company Profile
International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments.
Featured Articles
- Five stocks we like better than International Biotechnology
- Why is the Ex-Dividend Date Significant to Investors?
- S&P 500 Hitting Resistance: These 3 Stocks Offer the Best Upside
- Investing in Travel Stocks Benefits
- Nike’s Post-Earnings Drop Presents a Buying Opportunity
- About the Markup Calculator
- Microsoft’s Targeted Upside Might Be Too Good to Ignore
Receive News & Ratings for International Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.